External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ARVO 2022
Roche and Genentech at

ARVO 2022

May 01 - May 04
Denver, USA/ Virtual (Hybrid)
arvo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:42 AM
Duration 10mins Virtual
Prediction of Proliferative Diabetic Retinopathy (PDR) from Nonproliferative Diabetic Retinopathy (NPDR) Using Real-world (RW) Electronic Health Record (EHR) Data
Babiuch A, Yang Q, Damopoulos D, Rizzo S,Valentim C, Wu A, Benmansour F, Luu J, Kalur A, Sastry R, Iyer A, Muste J, Spicer G, Ferrara D, Singh R
Ophthalmology | Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:30 PM
Duration 10mins Four Seasons Blrm 1
Development and Validation of Prognostic Models to Increase Power of Clinical Trials for Geographic Atrophy (GA)
Steffen V, Anegondi N, Yang Q, Friesenhahn M, Ferrara D, Gao S, Rabe C
Ophthalmology | Geographic Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:21 AM
Duration 10mins Four Seasons Blrm 1
Quantification of Lesion Size Progression of Incomplete and Complete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration
Schmitz-Valckenberg S, Sassmannshausen M, Braun M, Steffen V, Gao S, Honigberg L, Ferrara D, Pfau M, Holz F
Ophthalmology | Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:47 PM
Duration 10mins Room: 205/207
Efficacy, durability, and safety of faricimab in diabetic macular edema: 2-year results from the phase 3 YOSEMITE and RHINE trials
Lim JI, Wells JA, Eichenbaum DA, Danzig C, Asik K, Haskova Z, Mohan S, Silverman D, Tang Y, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:04 PM
Duration 10mins Room: 205/207
Faricimab in neovascular age-related macular degeneration: updated week 48 efficacy, safety, and durability in the phase 3 TENAYA and LUCERNE trials
London N, Guymer R, Demetriades AM, Quezada Ruiz C, Silverman D, Ives J, Basu K, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:21 PM
Duration 10mins Virtual
Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results
Mittra R, Brooks L, Wykoff C, Callaway N, DeGraaf S, Fung AE, Gune S, LePogam S, Smith R, Willis J, Barteselli G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:30 PM
Duration 10mins Room: 2B/3B
Use of collagen-hybridizing peptides to assess active fibrosis in two mouse models of choroidal neovascularization
Westenskow P, Bennink L, Foxton R, Kirkness M, Linder M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:04 PM
Duration 10mins Virtual
Personalized treatment interval (PTI) dosing dynamics over 2 years in the phase 3 YOSEMITE and RHINE trials of faricimab in diabetic macular edema
Baumal CR, Kitchens JW, Jaffe GJ, Gerendas BS, Abreu F, Asik K, Camino A, Jain N, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:38 PM
Duration 10mins Four Seasons Blrm 1
Feature Discovery Using Ablation Studies for Deep Learning–Based Geographic Atrophy (GA) Progression Prediction
Cluceru J, Anegondi N, Yang Q, Steffen V, Rabe C, Friesenhahn M, Ferrara D, Gao S
Ophthalmology | Geographic Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:17 PM
Duration 10mins Room: 1EF Mile High Blrm (Denver Convention Center)
Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab
Adam M, Barras L, Maia M, Gune S, Maass K, Chang M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.